The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
mGluR5 Antagonist MPEP Reduces Ethanol-Seeking and Relapse Behavior
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Gasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P. J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendorn, R., Urwyler, S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00082-9 · Cited by 725 · cited 1×
“…by Chiamulera et al (2001) demonstrated the absence of cocaine self-administration in mGluR5 knockout mice and the dose-dependent reduction of cocaine self-administration following the administration of the selective antagonist 2-methyl-6(phenylethynyl)-pyridine (MPEP) (Gasparini et al, 1999).”
BackgroundInfluential
Cited by
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 634
Self-citationNeuropharmacology of alcohol addiction
Vengeliene, V, Bilbao, A., Molander, A., & Spanagel, R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.30 · Cited by 571
Self-citationGlutamatergic substrates of drug addiction and alcoholism
Gass, J. T., & Olive, M. F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.039 · Cited by 484
Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
HEILIG, M., & EGLI, M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.001 · Cited by 377
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference
Choi, D.-S., Cascini, M.-G., Mailliard, W., Young, H., Paredes, P., McMahon, T., Diamond, I., Bonci, A., & Messing, R. O. (2004) · Nature Neuroscience · doi:10.1038/nn1288 · Cited by 255
Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220
Glutamatergic targets for new alcohol medications
Holmes, A., Spanagel, R., & Krystal, J. H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3226-2 · Cited by 197
Self-citationConceptual framework for the etiology of alcoholism: a “kindling”/stress hypothesis
Breese, G. R., Overstreet, D. H., & Knapp, D. J. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2016-2 · Cited by 167
Spanagel, R. (2020) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2020.22.3/rspanagel · Cited by 127
Self-citationBlednov, Y. A., & Adron Harris, R. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008584 · Cited by 123
Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence
Alasmari, F., Goodwani, S., McCullumsmith, R. E., & Sari, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.10.001 · Cited by 85
Kufahl, P. R., Martin-Fardon, R., & Weiss, F. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.174 · Cited by 72
“…reserved 0893-133X/11 www.neuropsychopharmacology.org withdrawal states (Blednov and Harris, 2008; Sidhpura et al, 2010), and processes that convey vulnerability to relapse (Adams et al, 2010; Backstrom et al, 2004; Rodd et al, 2006; Schroeder et al, 2008; Sidhpura et al, 2010; Zhao et al, 2006).”
BackgroundAddiction, cognitive decline and therapy: Seeking ways to escape a vicious cycle
Perry, C. J., & Lawrence, A. J. (2017) · Genes, Brain and Behavior · doi:10.1111/gbb.12325 · Cited by 60
Hwa, L., Besheer, J., & Kash, T. (2017) · F1000Research · doi:10.12688/f1000research.9609.1 · Cited by 39
Yohn, S. E., Galbraith, J., Calipari, E. S., & Conn, P. J. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00601 · Cited by 36
Metadata
- Authors
- Bäckström, P., Bachteler, D., Koch, S., Hyytiä, P., & Spanagel, R.
- Venue
- Neuropsychopharmacology
- Published
- 2003-12-16
- Volume
- 29
- Issue
- 5
- Pages
- 921-928
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1983982251
- Cited by
- 249
- References
- 2
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.